Skip to main content

About DMG Agency

With decades of collective experience in global biopharma communications, DMG Agency turns news into measurable growth.

Founded in Palo Alto – with offices in Sydney, Singapore, and the EU – we’ve helped companies of every size, from emerging biotechs to top-tier pharma and CROs, secure investor capital, win marquee partnerships, and fill pipelines with qualified leads.

What sets us apart

  • Earned-media mastery
    Our specialty is high-impact, third-party coverage—the most trusted content in today’s crowded media landscape. We don’t just place stories; we amplify them across every digital channel to keep your brand in front of decision-makers.

  • Proven global reach
    A seasoned business-media team leverages deep relationships with journalists and editors worldwide, ensuring your story lands where it matters most.

  • Results you can track
    From investor interest to M&A inquiries, we tie every campaign to concrete KPIs that show real business value.

Our heritage

DMG Agency was founded by Susan Fitzpatrick-Napier, former health journalist and communications strategist, on a simple belief: compelling news and expert storytelling are the fastest paths to reputation – and revenue – in biopharma.

Let us put that power to work for you.

Book a briefing with us

Founded by health business journalist and biopharma communications specialist Susan Fitzpatrick-Napier

Success

We have also helped our clients secure more than $5B in funding, run successful IPO media programs and roadshows, and developed and managed investor engagement programs to support company value and growth.

Our team has arranged interviews for clients with the world’s leading media including CNN, New York Times, Wall Street Journal, The Economist, Reuters, AP and Bloomberg. Plus the most influential trade media reporting on biotech, pharma, health, finance and investment, and the life sciences sectors.

Book a briefing with us